These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27535130)

  • 1. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
    Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
    Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma.
    Dunkel Y; Reid AL; Ear J; Aznar N; Millward M; Gray E; Pearce R; Ziman M; Ghosh P
    Sci Rep; 2018 Dec; 8(1):18036. PubMed ID: 30575751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and cross-validation of gene expression signatures and melanoma prognosis.
    Schramm SJ; Campain AE; Scolyer RA; Yang YH; Mann GJ
    J Invest Dermatol; 2012 Feb; 132(2):274-83. PubMed ID: 21956122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.
    Lanigan F; Brien GL; Fan Y; Madden SF; Jerman E; Maratha A; Aloraifi F; Hokamp K; Dunne EJ; Lohan AJ; Flanagan L; Garbe JC; Stampfer MR; Fridberg M; Jirstrom K; Quinn CM; Loftus B; Gallagher WM; Geraghty J; Bracken AP
    FEBS J; 2015 Sep; 282(18):3455-73. PubMed ID: 26094870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
    Figueroa JD; Yang H; Garcia-Closas M; Davis S; Meltzer P; Lissowska J; Horne HN; Sherman ME; Lee M
    Breast Cancer Res Treat; 2015 Apr; 150(2):457-466. PubMed ID: 25773928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
    Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
    BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of gene expression in sentinel lymph node of primary breast cancer patients.
    Soleimani S; Alizadeh Shargh S; Keramatinia A; Mehrvar N; Mansouri N; Doosti A; Mortazavi-Tabatabaei SA; Hashemi M; Movafagh A
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):118-121. PubMed ID: 29729704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.
    Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S
    Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
    Jayawardana K; Schramm SJ; Tembe V; Mueller S; Thompson JF; Scolyer RA; Mann GJ; Yang J
    J Invest Dermatol; 2016 Jan; 136(1):245-254. PubMed ID: 26763444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
    Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
    Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy for melanoma: an update after two decades of experience.
    Ross MI
    Semin Cutan Med Surg; 2010 Dec; 29(4):238-48. PubMed ID: 21277537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
    Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
    PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
    Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
    Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
    Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
    Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
    Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
    Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
    Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.